ElectroMotive drug administration (EMDA) of mitomycin C as first line salvage therapy in high risk “BCG-failure” non muscle invasive bladder cancer: 3 years followup outcomes

L. Di Gianfrancesco; M. Racioppi; M. Raaonese; G. Palermo; N. Lenci; E. Sacco; P.F. Bassi

doi:10.1016/s1569-9056(18)31573-2

ElectroMotive drug administration (EMDA) of mitomycin C as first line salvage therapy in high risk “BCG-failure” non muscle invasive bladder cancer: 3 years followup outcomes

European Urology Supplements ◽

10.1016/s1569-9056(18)31573-2 ◽

2018 ◽

Vol 17 (2) ◽

pp. e1064

Author(s):

L. Di Gianfrancesco ◽

M. Racioppi ◽

M. Raaonese ◽

G. Palermo ◽

N. Lenci ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Salvage Therapy ◽

First Line ◽

Muscle Invasive Bladder Cancer ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

MP83-01 ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C AS FIRST LINE SALVAGE THERAPY IN HIGH RISK “BCG-FAILURE” NON MUSCLE INVASIVE BLADDER CANCER: 3 YEARS FOLLOWUP OUTCOMES

The Journal of Urology ◽

10.1016/j.juro.2018.02.2749 ◽

2018 ◽

Vol 199 (4S) ◽

Cited By ~ 1

Author(s):

Luca Di Gianfrancesco ◽

Marco Racioppi ◽

Mauro Ragonese ◽

Giuseppe Palermo ◽

Niccolò Lenci ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Salvage Therapy ◽

First Line ◽

Muscle Invasive Bladder Cancer ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

BMC Cancer ◽

10.1186/s12885-018-5134-7 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 11

Author(s):

Marco Racioppi ◽

Luca Di Gianfrancesco ◽

Mauro Ragonese ◽

Giuseppe Palermo ◽

Emilio Sacco ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Salvage Therapy ◽

First Line ◽

Muscle Invasive Bladder Cancer ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

MP56-15 SEQUENTIAL BCG / ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) MITOMYCIN C (MMC) AS THE STANDARD INTRAVESICAL REGIMEN IN HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) – ONE YEAR OUTCOMES

The Journal of Urology ◽

10.1016/j.juro.2014.02.1583 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Christine Gan ◽

Suzanne Amery ◽

Kathryn Chatterton ◽

Muhammad Shamim Khan ◽

Kay Thomas ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

One Year ◽

Electromotive Drug Administration

Download Full-text

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

The Journal of Urology ◽

10.1097/ju.0000000000000959.01 ◽

2020 ◽

Vol 203 ◽

pp. e1121

Author(s):

Tristan Juvet* ◽

Christopher Wallis ◽

Lior Krimus ◽

Cynthia Kuk ◽

Annette Erlich ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

High Grade ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Sequential Administration ◽

Bcg Failure ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in high risk non muscle invasive bladder cancer – results from a retrospective analysis

European Urology Supplements ◽

10.1016/s1569-9056(18)33383-9 ◽

2018 ◽

Vol 17 (8) ◽

pp. 357-358

Author(s):

F. Di Modugno ◽

V. Pagliarulo ◽

A. Procacci ◽

F. Bianchi ◽

S. Tafuri ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Retrospective Analysis ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Intravesical sequential BCG/electromotive drug administration Mitomycin C (EMDA-MMC) in patients with primitive and recurrent high risk non muscle invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(19)33635-8 ◽

2019 ◽

Vol 18 (9) ◽

pp. e3249

Author(s):

F. Di Modugno ◽

S. Forte ◽

V. Pagliarulo ◽

G. Lucarelli ◽

V. Pastoressa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Will long-term disease specific outcomes of bladder conservation with sequential Bacillus Calmette-Guérin (BCG) and electromotive drug administration Mitomycin-C (EMDA-MMC) for high-risk non-muscle invasive bladder cancer (HR-NMIBC) influence adoption?

Frontiers in Oncology ◽

10.3389/conf.fonc.2019.01.00015 ◽

2019 ◽

Vol 9 ◽

Author(s):

Jennifer Lane ◽

Zakariya Abdille ◽

Christine Gan ◽

Kathryn Chatterton ◽

Suzanne Amery ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Drug Administration ◽

Bacillus Calmette Guerin ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration ◽

Disease Specific

Download Full-text

1045 Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial

European Urology Supplements ◽

10.1016/s1569-9056(12)61041-0 ◽

2012 ◽

Vol 11 (1) ◽

pp. e1045-e1045a ◽

Cited By ~ 1

Author(s):

S.M. Di Stasi ◽

C. Verri ◽

E. Liberati ◽

F. Micali ◽

F. Masedu ◽

...

Keyword(s):

Bladder Cancer ◽

Randomized Controlled Trial ◽

Mitomycin C ◽

Drug Administration ◽

Controlled Trial ◽

Intermediate Risk ◽

Muscle Invasive Bladder Cancer ◽

Randomized Controlled ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

Updates in intravesical electromotive drug administration® of mitomycin-C for non-muscle invasive bladder cancer

World Journal of Urology ◽

10.1007/s00345-009-0389-x ◽

2009 ◽

Vol 27 (3) ◽

pp. 325-330 ◽

Cited By ~ 24

Author(s):

Savino Mauro Di Stasi ◽

Claus Riedl

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Drug Administration ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Electromotive Drug Administration

Download Full-text

PD19-06 HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC) TREATED WITH SEQUENTIAL BCG / ELECTROMOTIVE DRUG ADMINISTRATION MITOMYCIN-C (EMDA-MMC): 2% DISEASE-SPECIFIC MORTALITY AT 4 YEARS' FOLLOW-UP

The Journal of Urology ◽

10.1016/j.juro.2017.02.879 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Christine Gan ◽

Suzanne Amery ◽

Kathryn Chatterton ◽

Muhammad Shamim Khan ◽

Kay Thomas ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Muscle Invasive Bladder Cancer ◽

Specific Mortality ◽

Disease Specific Mortality ◽

Muscle Invasive ◽

Electromotive Drug Administration ◽

Disease Specific

Download Full-text